0 likes | 2 Vues
This PPT details how SPECT/CT-based dosimetry is performed after each cycle of Tb-161 therapy. It shows how clinicians use this data to customize and adjust doses, minimizing toxicity and improving treatment precision in prostate cancer care. Know more at https://nuclearmedicinetherapy.in/
E N D